Advanced Therapeutics

892 papers and 12.2k indexed citations i.

About

The 892 papers published in Advanced Therapeutics in the last decades have received a total of 12.2k indexed citations. Papers published in Advanced Therapeutics usually cover Biomedical Engineering (332 papers), Molecular Biology (327 papers) and Biomaterials (190 papers) specifically the topics of Nanoplatforms for cancer theranostics (218 papers), Nanoparticle-Based Drug Delivery (140 papers) and RNA Interference and Gene Delivery (132 papers). The most active scholars publishing in Advanced Therapeutics are Karli A. Gold, Mark Knackstedt, Akhilesh K. Gaharwar, Yang Shi, Hossein Etemadi, Richard Hoogenboom, Ondřej Sedláček, Paul G. Plieger, Hélder A. Santos and Nicolas H. Voelcker.

In The Last Decade

Fields of papers published in Advanced Therapeutics

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Advanced Therapeutics. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Advanced Therapeutics

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Advanced Therapeutics. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Advanced Therapeutics with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025